{
    "Overall_score": {
        "Correlation": 9,
        "Sentiment": 6,
        "Importance": 8,
        "Impact": 7,
        "Duration": 5,
        "Virality": 4,
        "Source_Score": 7,
        "Specificity": 8,
        "Sector_Spread": 6,
        "Tech_Mentions": 2
    },
    "Each_item": [
        {
            "News_content": "Pfizer renews bid interest in AstraZeneca",
            "Correlation": 10,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 7,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 5,
            "Tech_Mentions": 1
        },
        {
            "News_content": "$PFE Form 8.3 - Pfizer Inc",
            "Correlation": 9,
            "Sentiment": 5,
            "Importance": 7,
            "Impact": 6,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 8,
            "Specificity": 9,
            "Sector_Spread": 3,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Winners like $PFE $NU $CHK $CSIQ",
            "Correlation": 7,
            "Sentiment": 6,
            "Importance": 5,
            "Impact": 5,
            "Duration": 3,
            "Virality": 4,
            "Source_Score": 6,
            "Specificity": 6,
            "Sector_Spread": 8,
            "Tech_Mentions": 1
        },
        {
            "News_content": "$AZN Rejects $PFE Proposal. Terms Inadequate, Undervalue $AZN",
            "Correlation": 10,
            "Sentiment": 3,
            "Importance": 9,
            "Impact": 8,
            "Duration": 7,
            "Virality": 6,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 4,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Novartis at the top. How the big boys in Big Pharma stack up today $AZN $PFE",
            "Correlation": 8,
            "Sentiment": 5,
            "Importance": 6,
            "Impact": 5,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 7,
            "Specificity": 7,
            "Sector_Spread": 7,
            "Tech_Mentions": 1
        },
        {
            "News_content": "$PFE - EUROPE MARKETS: European Stocks Waver, But RBS Rallies On Profit Report",
            "Correlation": 6,
            "Sentiment": 5,
            "Importance": 5,
            "Impact": 4,
            "Duration": 3,
            "Virality": 2,
            "Source_Score": 7,
            "Specificity": 6,
            "Sector_Spread": 5,
            "Tech_Mentions": 1
        },
        {
            "News_content": "$AZN board has just announced rejection of Â£50 a share $PFE bid",
            "Correlation": 10,
            "Sentiment": 3,
            "Importance": 9,
            "Impact": 8,
            "Duration": 7,
            "Virality": 6,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 4,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Pfizer Sends Letter to Rt Hon David Cameron MP Regarding Commitments If Proposed Combination with AstraZene",
            "Correlation": 9,
            "Sentiment": 6,
            "Importance": 8,
            "Impact": 7,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 8,
            "Specificity": 8,
            "Sector_Spread": 5,
            "Tech_Mentions": 1
        },
        {
            "News_content": "More info on $SCG $PX $PFE $AAPL",
            "Correlation": 6,
            "Sentiment": 5,
            "Importance": 4,
            "Impact": 4,
            "Duration": 3,
            "Virality": 3,
            "Source_Score": 6,
            "Specificity": 5,
            "Sector_Spread": 7,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Pfizer's Bid for AstraZeneca Tricky for U.K. --Update",
            "Correlation": 9,
            "Sentiment": 5,
            "Importance": 7,
            "Impact": 6,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 5,
            "Tech_Mentions": 1
        },
        {
            "News_content": "UPDATE 6-AstraZeneca rejects Pfizer's raised bid of $106 bln $PFE",
            "Correlation": 10,
            "Sentiment": 3,
            "Importance": 9,
            "Impact": 8,
            "Duration": 7,
            "Virality": 6,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 4,
            "Tech_Mentions": 1
        },
        {
            "News_content": "AstraZeneca dismisses Pfizer's $106B bid, ignores R&D commitment $AZN $PFE",
            "Correlation": 10,
            "Sentiment": 3,
            "Importance": 9,
            "Impact": 8,
            "Duration": 7,
            "Virality": 6,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 4,
            "Tech_Mentions": 1
        }
    ]
}